Food and Relative Bioavailability Study

• Status: Completed
• Trial end date: 2008-10-23

Summary

This study is an open-label, randomised, single dose study to determine the pharmacokinetics, safety and tolerability of 2 different formulations of orvepitant 60 mg and the effect of food in 15 Healthy Volunteers.

• Phase: Phase 1

Details

• Lead Sponsor: GlaxoSmithKline